Share on LinkedInShare on LinkedIn

ARTICLE · 05 JULY 2023

EU & Competition Newsletter – 1/2023

Waselius
Waselius
Contributor
Waselius

Waselius

Waselius is a leading Finnish business law firm, committed to provide highly specialised legal...

View firm profile
Explore more from Waselius

We are pleased to provide you with this Quarterly EU & Competition Newsletter, which summarises selected key highlights and recent developments in Finnish and EU competition law during the last quarter of 2022.

European UnionAntitrust/Competition Law

We are pleased to provide you with this Quarterly EU & Competition Newsletter, which summarises selected key highlights and recent developments in Finnish and EU competition law during the last quarter of 2022. We hope our newsletter will help you stay on track and welcome you to contact us for any questions or comments.

ANTITRUST & MERGERS

European Union

Commission prohibited acquisition of GRAIL by Illumina

In a much-debated decision, the European Commission on 6 September 2022 prohibited the U.S. life sciences firm Illumina, a supplier of NGS systems for genetic and genomic analysis, from acquiring its customer GRAIL, a biotechnology company. The case was referred to the Commission under Article 22 of the EU Merger Regulation and the proposed transaction was not notifiable in the referring Member States (and was not notified in any other Member States).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from